Fortis Group Advisors’s AbbVie ABBV Stock Holding History

Fortis Group Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.4K	Hold	69	–	–	﹤0.01%	355
2026 Q1	$15K	Hold	69	–	–	﹤0.01%	364
2025 Q4	$15.8K	Hold	69	–	–	﹤0.01%	356
2025 Q3	$16K	Hold	69	–	–	﹤0.01%	314
2025 Q2	$12.8K	Buy	69 +36	+109%	+$6.69K	﹤0.01%	321
2025 Q1	$6.91K	Hold	33	–	–	﹤0.01%	326
2024 Q4	$5.86K	Hold	33	–	–	﹤0.01%	350
2024 Q3	$6.52K	Hold	33	–	–	﹤0.01%	336
2024 Q2	$5.66K	Sell	33 -1,766	-98%	-$293K	﹤0.01%	341
2024 Q1	$328K	Sell	1,799 -128	-7%	-$22.1K	0.06%	158
2023 Q4	$307K	Buy	1,927 +33	+2%	+$4.81K	0.08%	98
2023 Q3	$301K	Buy	1,894 +33	+2%	+$4.84K	0.09%	96
2023 Q2	$251K	Hold	1,861	–	–	0.07%	116
2023 Q1	$281K	Buy	+1,861	New	+$285K	0.08%	97
2020 Q3	$267K	Buy	+3,065	New	+$289K	0.05%	159

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Fortis Group Advisors's ABBV Position: Q2 2026 in Review

Fortis Group Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 69 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #355.

Fortis Group Advisors first reported a position in ABBV in Q3 2020 and has held it in 15 quarters since. The position peaked at $328K in Q1 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fortis Group Advisors held 69 shares of AbbVie worth $17.4K as of Q2 2026.
Fortis Group Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up ﹤0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #355 holding.
Fortis Group Advisors first reported a position in AbbVie in Q3 2020 and has held it in 15 quarters since.
Fortis Group Advisors's AbbVie position peaked at $328K in Q1 2024.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.